- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT01899196
Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients (ANRS EP 52)
EPICARDIAL ADIPOSE TISSUE AND CORONARY RISK IN HIV-INFECTED PATIENTS
Protocol date and version RCB Id : 2013-A00547-38
Etude ANRS EP 52 PIECVIH Title of Study: EPICARDIAL ADIPOSE TISSUE AND CORONARY RISK IN HIV-INFECTED PATIENTS
Short title - PIECVIH study
Sponsor French National Institute for Health and Medical Research - French national agency for research on AIDS and viral hepatitis (Inserm-ANRS)
Coordinating Investigator Pr Franck BOCCARA Service de Cardiologie, Hôpital St Antoine INSERM UMRS 938 Paris, UPMC, Institut hospitalo-Universitaire- Institute of Cardiometabolism and Nutrition (IHU-ICAN) 184, rue du Faubourg Saint-Antoine 75571 PARIS Cedex 12 Tél. : 01 49 28 24 49 - Fax : 01 49 28 26 83 Courriel : franck.boccara@sat.aphp.fr
Participating country: France
Objectives Principal objective To compare the inflammatory profile of the epicardial adipose tissue (EAT) between people living with and without HIVwho present with coronary heart disease and will undergo a coronary artery bypass graft (CABG)
Secondary objectives
- To compare the volume of EAT between people living with and without HIV who present with coronary heart disease
- To evaluate the relationship between the abnormalities of the expression profiles of the adipocytokines and cytokines with the atherosclerotic lesions.
- To evaluate the relationship between the abnormalities of the expression profiles of the adipocytokines and cytokines of the EAT with the circulating levels and metabolic parameters.
- To compare the histological and inflammatory profiles of the EAT with the subcutaneous adipose tissue for each patient individually.
Methodology multicentric, comparative study
Estimated enrollment 31 participants in total
- st group of- 15 people living with HIV undergoing CABG (coronary heart disease HIV+ group)
- nd group of- 16 people without HIV- undergoing CABG (coronary heart disease HIV- group) People without HIV-will be matched to people living with HIV+ by : age (± 5 years) and sex Outcomes
Primary outcome:
Comparative analysis of the inflammatory profile of the EAT : expression profile of the pro and anti inflammatory cytokines and adipokines within the EAT in both groups of participants : coronary heart disease HIV+ and HIV- groups
Secondary outcomes :
- Determination of the EAT volume by echocardiography and cardiac scanner for both groups
- Macroscopic profile of the EAT : adipocytes, fibrosis, endothelial cell density)
- RT-PCR analyses : renin, adiponectine, PPARɣ
- Comparatison of the inflammatory and macroscopic profiles between the EAT and the subcutaneous adipose tissue in the two groups by ARN messagers analysis.
Eligibility Inclusion criteria HIV+ group
- Men or women above the age of 18 years old, HIV1 seropositive for more than 6 months
- Individual undergoing, for the first time, cardiac surgery for CABG
- Affiliated with a social security regimen (the AME is not a social security regimen)
- Signed the consent form
HIV- group
- Men or women above the age of 18 years old, HIV seronegative
- Individuals undergoing, for the first time, cardiac surgery for CABG
- Affiliated with a social security regimen (the AME is not a social security regimen)
- Signed the consent form
Non-inclusion criteria History of surgery for CBAG and/or congenital heart defect- being under the tutorship or guardianship of the state or in custody of the justice system.
Statistical methods Categorical variables will be compared using Fisher's exact test. Continuous variables will be compared using the Student's t-test (parametric) and the Wilcoxon-Mann-Whitney test (non-parametric) as appropriate considering the data distribution. (statistical analysis software STATA 11 (StataCorp, Texas, USA))
Provisional study planning and timetable Study start date: July 2013 Enrollment period: 32 months Subject participation duration: 24 hours Total study duration: 32 months Estimated study completion date: end of March 2016
Panoramica dello studio
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Paris, Francia, 75012
- Hospital St Antoine
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
VIH + GROUP:
- Men or women > 18 years old, HIV1 + for more than 6 months
- Planned first cardiac surgery for CABG
VIH - GROUP:
- Men or women > 18 years old,
- Planned first cardiac surgery for CABG
Exclusion Criteria:
- History of cardiac surgery
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Altro: no Arm
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Lasso di tempo |
---|---|
comparison of the inflammatory profile of the epicardial adipose (EAT) tissue between HIV-infected and uninfected patients undergoing cardiac surgery for coronary artery bypass graft (CABG)
Lasso di tempo: day 1
|
day 1
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
---|---|
comparison the volume of EAT between HIV-infected and uninfected patients undergoing cardiac surgery
Lasso di tempo: day 1
|
day 1
|
Evaluation of the relations between the adipocytokines and cytokines profile in the EAT and in the systemic circulation.
Lasso di tempo: day 1
|
day 1
|
Comparison of the histological and inflammatory profiles of the EAT and the subcutaneous adipose tissue of each patients.
Lasso di tempo: day 1
|
day 1
|
Evaluation of the relations between the adipocytokines and cytokines profile in the EAT and coronary artery lesions.
Lasso di tempo: day 1
|
day 1
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Pascal LEPRINCE, Hôpital La Pitié Salpétrière Paris
Studiare le date dei record
Studia le date principali
Inizio studio
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Infezioni da virus a RNA
- Malattie virali
- Infezioni
- Infezioni a trasmissione ematica
- Malattie trasmissibili
- Malattie sessualmente trasmissibili, virali
- Malattie trasmesse sessualmente
- Infezioni da lentivirus
- Infezioni da retroviridae
- Sindromi da deficit immunologico
- Malattie del sistema immunitario
- Infezioni da HIV
Altri numeri di identificazione dello studio
- ANRS EP 52 PIECVIH
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Infezione da Hiv
-
University of MinnesotaRitiratoInfezioni da HIV | HIV/AIDS | HIV | AIDS | Problema di Aids/Hiv | AIDS e infezioniStati Uniti
-
Erasmus Medical CenterNon ancora reclutamentoInfezioni da HIV | HIV | Infezione da HIV-1 | Infezione da HIV IOlanda
-
Helios SaludViiV HealthcareSconosciutoHIV | Infezione da HIV-1Argentina
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement; Centre Pasteur du Cameroun e altri collaboratoriSconosciutoHIV | Bambini non infetti da HIV | Bambini esposti all'HIVCamerun
-
University of MinnesotaCompletatoInfezioni da HIV | HIV | ImmunodeficienzaStati Uniti
-
Midway Specialty Care CenterNon ancora reclutamentoInfezioni da HIV | HIV | Infezione da HIV-1Stati Uniti
-
Allegheny Singer Research Institute (also known...Attivo, non reclutanteInfezioni da HIV | Infezione da HIV-1 | Infezione da HIV IStati Uniti
-
University of California, DavisCompletato
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completato
-
University of ZimbabweCompletato
Prove cliniche su blood sampling,
-
Haydarpasa Numune Training and Research HospitalCompletatoDisturbo della coagulazioneTacchino
-
Cerus CorporationReclutamento
-
University Hospital, RouenNon ancora reclutamentoEpatite B | Epatite C | AIDSFrancia
-
MicroPhage, Inc.CompletatoSepsi | Batteriemia | Infezione | Infezione da stafilococcoStati Uniti
-
University Hospital TuebingenReclutamentoPredisposizione genetica alla malattia | Malattie RareGermania
-
University of UtahAlbert Einstein College of Medicine; University of California, San Francisco; National... e altri collaboratoriCompletato
-
Cerus CorporationTerminatoMalattia acuta da virus EbolaStati Uniti
-
University of the Balearic IslandsCompletatoPressione sanguigna | Allenamento di resistenzaSpagna
-
Tokat Gaziosmanpasa UniversityCompletatoDenti decidui | Pulpotomia | Sanguinamento pulpare; ColorazioneTacchino
-
Universidade Federal do CearaNon ancora reclutamento